Anti-Mouse PLVAP (MECA-32) In Vivo Antibody - Low Endotoxin

In stock
Only %1 left
SKU
ICH1264
Add to Compare
$400.00 - $2,945.00

Anti-Mouse PLVAP (MECA-32) In Vivo Antibody - Low Endotoxin

Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE
Target
PLVAP
Concentration
>1.0 mg/ml
Isotype
Rat IgG2a
Host
Rat
Buffer
ICH3002
Uniprot
Q9BX97
Shipping Conditions
Blue ice
Background
PLVAP is an endothelial protein that forms the diaphragms of fenestrae and caveolae and helps regulate vascular permeability and trans-endothelial transport. Clone MECA-32 is a rat IgG2a monoclonal antibody recognising mouse PLVAP, validated for ELISA, flow cytometry, neutralization, and functional assays. Anti-PLVAP MECA-32 is supplied in a low-endotoxin format suitable for in vivo use and produced in scalable milligram to gram quantities for bulk and high-throughput laboratories. As a research-use-only, non-therapeutic reagent, it delivers reproducible, lot-consistent performance for mouse vascular biology, endothelial barrier, and angiogenesis research.
Other Names
PV1; Plasmalemma vesicle-associated protein; Plasmalemma vesicle protein 1
Purification Method
All the monoclonal antibodies in this panel were purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –20°C or –80°C. Avoid Repeated Freeze Thaw Cycles.
Applications
ELISA, flow cytometry, neutralization, functional assays
Application Notes
This antibody is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Write Your Own Review
You're reviewing:Anti-Mouse PLVAP (MECA-32) In Vivo Antibody - Low Endotoxin
Your Rating
Back to Top